Joe Bondy-Denomy solves a CRISPR caper: this is how a viral protein stows itself on protein factories in bacteria, and destroys a CRISPR protein, designed to kill viruses, while it's being made.

Platform data establish Modified DNA’s potential to overcome two of the barriers that have kept DNA from becoming a practical ...

A team of Rice University bioengineers has developed a new way to create highly realistic "mock" patient samples that could ...

I n December 2020, mRNA vaccines leapt into the limelight as a response to the COVID-19 pandemic. To date, millions of people ...

NunaBio secures £6.5 mn to scale next-generation DNA platform and advance infrastructure for synthetic biology: Newcastle, UK Wednesday, May 13, 2026, 18:00 Hrs [IST] NunaBio, a ...

The CEO of Caszyme, a biotech company in Vilnius, Lithuania, presented details of Cas12l, a novel compact Cas nuclease with a ...

PLC('4basebio' or the 'Company')4basebio Launches Enzymatic ssDNA PlatformOvercomes critical manufacturing and performance ...

Appointment of Chief Financial Officer and Board Changes · Richard Bungay appointed as CFO, bringing a strong track record in fundraising, M&A and partnering for listed and private companies, ...

Richard Bungay appointed as CFO, bringing a strong track record in fundraising, M&A and partnering for listed and private companies, including two major exits and over $400m raisedCambridge, UK, 14 ...

His method was safer than variolation because it used a related but far less dangerous virus. He called the procedure vaccination, from vacca, the Latin word for cow. Jenner’s work, published in 1798, ...

Optimized additive selection could help yeast-based cell-free protein expression systems fulfill their potential at commercial scale.

The MV Hondius outbreak has renewed focus on hantavirus vaccines, with Moderna developing an mRNA-based shot. The Andes ...